1. Actions for FDA SEND: What pathologists/toxicologists need to know. (16th September 2016) Authors: Anzai, T.; Hatakeyama, H.; Horikawa, S.; Sakurai, J.; Iwata, H.; Aerni, R.; Mura, F.; Wasko, M.; Kaufman, L. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FDA SEND in non-US countries responses to the standard for exchange of nonclinical data (SEND) in non-US countries. (16th October 2015) Authors: Anzai, T.; Kaufman, L.; Aerni, R.; Mura, F.; Schuster, M.; Buchanan, R.; Wasko, M. Journal: Toxicology letters Issue: Volume 238(2015)Supplement Page Start: S165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FDA SEND process streamlining and implementation – CT-compatible simulated study. (10th October 2018) Authors: Anzai, T.; Aerni, R.; Wasko, M.; Mura, F.; Horikawa, S.-I.; Sato, S.-I.; Murase, Y.; Hatakeyama, H. Journal: Toxicology letters Issue: Volume 295(2018) Page Start: S218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P21-01 Challenges and practical examples in creation of SEND data for developmental and reproductive toxicity studies. (1st September 2022) Authors: Anzai, T.; Ellison, M.; Wasko, M.; Horikawa, S.; Suyama, S.; Ushimaru, T.; Sato, S.; Iino, K. Journal: Toxicology letters Issue: Volume 368(2022)supplement 1 Page Start: S257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗